TKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumors

Amit Dipak Amin(University of Cambridge), Jonathan H. Schatz(University of Miami)
Oncotarget
March 18, 2016
Cited by 22


Related Papers